STRO
Sutro Biopharma
16.10$
-1.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 71.7% | 62.9% | 94.1% | 82.2% | 96.0% | 64.0% | 86.8% | 89.5% | 88.7% | 86.8% | |
| 16.7% | 54.0% | 56.2% | 3.2% | 52.3% | 8.9% | 11.6% | 14.7% | 49.1% | 33.4% | |
| 68.6% | 54.0% | 91.6% | 75.4% | 93.4% | 58.0% | 82.2% | 79.8% | 81.8% | 81.4% | |
| 0.8% | 4.0% | 1.1% | 4.0% | 1.4% | 3.6% | 1.8% | 7.7% | 2.2% | 2.3% | |
| – | – | 0.0% | – | – | 0.0% | -2.9% | 0.0% | – | – | |
| 27.0% | 34.3% | 4.9% | 6.2% | 3.3% | 15.1% | 12.5% | – | – | – | |
| 231.2% | 367.4% | 41.1% | 37.5% | 15.7% | 26.0% | 46.7% | 68.2% | 88.5% | 176.2% | |
| 72.4% | 78.4% | 16.3% | 21.1% | 7.5% | 12.2% | 16.4% | 19.9% | 34.1% | 43.2% | |
| 4.6% | 35.9% | 2.1% | 0.6% | 2.2% | 3.0% | 5.3% | 2.2% | 1.9% | 4.5% | |
| 4.9% | 7.1% | 1.4% | 3.6% | 1.4% | 1.8% | 1.2% | 2.0% | 2.7% | 4.4% | |
| 1.7% | 4.2% | 4.5% | 5.7% | 6.2% | 4.6% | 0.9% | – | – | – | |
| -131.2% | -267.4% | 58.9% | 62.5% | 84.3% | 74.0% | 53.3% | 31.8% | 11.5% | -76.2% | |
| -137.6% | -282.1% | -67.4% | -125.2% | -57.8% | -97.7% | -111.2% | -118.8% | -203.2% | -562.6% | |
| 0.1% | 17.2% | 1.0% | 1.5% | 8.3% | 1.4% | 1.2% | 1.3% | 2.0% | 4.9% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.